| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $468.60M | $372.10M | $209.70M | $119.70M | $91.20M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $67.10M | $70.70M | $79.60M | $71.50M | $49.20M |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $700.00K | $1.20M | $500.00K | $1.30M | $700.00K |
| Net Income | $57.70M | -$40.50M | -$273.10M | -$333.40M | -$371.40M |
| EPS (basic) | 2.2800 | -1.6400 | -11.5800 | -14.6600 | -1.3600 |
| EPS (diluted) | 2.2200 | -1.6400 | -11.5800 | -14.6600 | -1.3600 |
| Shares (diluted) | $26.01M | $24.70M | $23.58M | $22.75M | $272.17M |